Clinical Trials Browser

INDUSTRY × Radiation × Gastrointestinal × Clear all

Esophageal Squamous Cell Carcinoma

NCT03132922 2024-01-22

MAGE-A4ᶜ¹º³²T for Multi-Tumor

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Sarcoma, Stomach Neoplasms, Sarcoma, Synovial, Liposarcoma, Myxoid

NCT04426955 2021-09-16

Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer

Phase 3 Unknown

396 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT01748773 2019-10-09

TOXAG

Phase 2 Completed

34 enrolled

Gastrointestinal

Stomach Neoplasms

NCT03213054 2018-09-26

A Study of OBP-301 With Radiation Therapy in Patients With Esophageal Cancer

Phase 1 Unknown

12 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT01589419 2017-11-20

A Clinical Study Conducted in Multiple Centers Evaluating Escalating Doses of Veliparib in Combination With Capecitabine and Radiation in Patients With Locally Advanced Rectal Cancer

Phase 1 Completed

32 enrolled

Gastrointestinal

Locally Advanced Rectal Cancer

Clinical Trials

KUNLUN

MAGE-A4ᶜ¹º³²T for Multi-Tumor

Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer

TOXAG

A Study of OBP-301 With Radiation Therapy in Patients With Esophageal Cancer

A Clinical Study Conducted in Multiple Centers Evaluating Escalating Doses of Veliparib in Combination With Capecitabine and Radiation in Patients With Locally Advanced Rectal Cancer